The impact of nodal status on outcome in older patients with papillary thyroid cancer

Surgery (United States)

Volumn 156, Issue 1, 2014, Pages 137-146

  Nixon, Iain J ^a   Wang, Laura Y ^a   Palmer, Frank L ^a   Tuttle, R Michael ^a   Shaha, Ashok R ^a   Shah, Jatin P ^a   Patel, Snehal G ^a   Ganly, Ian ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; THYROID CARCINOMA;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84902545651     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.03.027     Document Type: Article

References (22)

1. A.R. Shaha, J.P. Shah, and T.R. Loree Risk group stratification and prognostic factors in papillary car cinoma of thyroid Ann Surg Oncol 3 1996 534 538
2. I.D. Hay, E.J. Bergstralh, J.R. Goellner, J.R. Ebersold, and C.S. Grant Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989 Surgery 114 1993 1050 1057 discussion 1057-8
3. B. Cady, and R. Rossi An expanded view of risk-group definition in differentiated thyroid carcinoma Surgery 104 1988 947 953
4. C.J. Hughes, A.R. Shaha, J.P. Shah, and T.R. Loree Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis Head Neck 18 1996 127 132
5. J. Harwood, O.H. Clark, and J.E. Dunphy Significance of lymph node metastasis in differentiated thyroid cancer Am J Surg 136 1978 107 112
6. S.B. Edge, and American Joint Committee on Cancer AJCC cancer staging manual 7th ed. 2010 Springer New York xiv, 648 p
7. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, and S.J. Mandel et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
8. E.L. Mazzaferri, and S.M. Jhiang Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 1994 418 428
9. S.I. Sherman, J.D. Brierley, M. Sperling, K.B. Ain, S.T. Bigos, and D.S. Cooper et al. Prospective multicenter study of thyrois]carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group Cancer 83 1998 1012 1021
10. B. Cady, C.E. Sedgwick, W.A. Meissner, J.R. Bookwalter, V. Romagosa, and J. Werber Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma Ann Surg 184 1976 541 553
11. R.N. Hirabayashi, and Lindsays Carcinoma of the thyroid gland: a statistical study of 390 patients J Clin Endocrinol Metab 21 1961 1596 1610
12. I. Sugitani, N. Kasai, Y. Fujimoto, and A. Yanagisawa A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period Surgery 135 2004 139 148
13. V. Zaydfudim, I.D. Feurer, M.R. Griffin, and J.E. Phay The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma Surgery 144 2008 1070 1077 discussion 1077-8
14. S. Leboulleux, C. Rubino, E. Baudin, B. Caillou, D.M. Hartl, and J.M. Bidart et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis J Clin Endocrinol Metab 90 2005 5723 5729
15. Y. Ito, M. Fukushima, C. Tomoda, H. Inoue, M. Kihara, and T. Higashiyama et al. Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment Endocr J 56 2009 759 766
16. S.G. de Meer, M. Dauwan, B. de Keizer, G.D. Valk, I.H. Borel Rinkes, and M.R. Vriens Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer World J Surg 36 2012 1262 1267
17. H. Takada, T. Kikumori, T. Imai, M. Sawaki, A. Shibata, and T. Kiuchi Patterns of lymph node metastases in papillary thyroid carcinoma: results from consecutive bilateral cervical lymph node dissection World J Surg 35 2011 1560 1566
18. B.H.-H. Lang, K.P. Wong, K.Y. Wan, and C.-Y. Lo Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection Ann Surg Oncol 19 2012 1257 1263
19. C.J. O'Neill, N. Coorough, J.C. Lee, J. Clements, L.W. Delbridge, and R. Sippel et al. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases ANZ J Surg 84 2014 240 244
20. J. Ricarte-Filho, I. Ganly, M. Rivera, N. Katabi, W. Fu, and A. Shaha et al. Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension Thyroid 22 2012 575 584
21. G. Randolph, Q.Y. Duh, K.S. Heller, V.A. Livolsi, S.J. Mandel, and D. Steward et al. The Prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension Thyroid 22 2012 1144 1152
22. S.H. Beal, S.L. Chen, P.D. Schneider, and S.R. Martinez An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma Am Surg 76 2010 28 32